The acquisition grows Medtronic’s ENT portfolio with the Propel and Sinuva product lines, according to a May 13 news release. Intersect ENT’s subsidiary company, Fiagon, was not included in the acquisition.
The $1.1 billion acquisition was announced in August.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
